Wedgewood Pharmacy Issues Recall of Certain Compounded Veterinary Medications Within Expiry Due to Potential Potency Issues

SWEDESBORO, N.J. (October 21, 2026) – Wedgewood Pharmacy LLC (“Wedgewood”) is recalling certain compounded veterinary medications within expiry at the provider/customer level due to inconsistencies in the reliability of certain analytical testing data generated by their laboratory, potentially resulting in subpotent and/or superpotent products. The affected products were shipped between February 18, 2026 and October 6, 2026 to veterinary practices, pharmacies, and other customers nationwide in the U.S. The issue was discovered through Wedgewood’s own quality processes. A complete list of affected products (including powders, pastes, oral suspensions, injectables, ophthalmic ointments and solutions, ear solutions and suspensions, topical sprays, and gels), lot numbers, and expiration dates are available at www.wedgewood.com/recall-lookup/. The products involved are intended for companion, equine, exotic, zoo, wildlife, and aquatic animals. They are not intended for use in food-producing animals.
Hazard Statement: The health risks involved with low potency can include ineffective treatment and the health risks involved with high potency can include toxicity or overdose. To date, Wedgewood has received 98 complaints, of which 7 are serious. Customers should contact their veterinarians if they have medical concerns.





